"Simone Boothe, diagnosed with myeloma in January 2017, experienced multiple collapses due to crashing haemoglobin levels, which were initially masked by her MS symptoms."
"Boothe was given a prognosis of three to seven years but maintained a positive outlook, stating, 'Nope, I'm going to be here much longer than that.'"
"After undergoing 41 rounds of chemotherapy, Boothe was offered a newly-approved drug in February 2025, which she described as 'absolutely, mind-blowingly, unbelievably successful.'"
Simone Boothe, 47, from Catford, was diagnosed with myeloma in January 2017 after experiencing multiple collapses. Initially misdiagnosed due to her MS symptoms, she underwent extensive testing and blood transfusions. Boothe was given a prognosis of three to seven years but remained positive. After 41 rounds of chemotherapy, she was offered a newly-approved drug in February 2025, which she described as life-saving. Boothe's journey highlights the challenges of diagnosing myeloma, especially in patients with pre-existing conditions like multiple sclerosis.
Read at www.bbc.com
Unable to calculate read time
Collection
[
|
...
]